The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global PD-L1 and PIK3CA Testing Market Research Report 2025
Synopsis
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global PD-L1 and PIK3CA Testing market was valued at US$ 521.8 million in 2023 and is anticipated to reach US$ 1964.3 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.
Report Scope
The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Segment by Type
PD-L1 Testing
PIK3CA Testing
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
PD-L1 Biomarker Testing measures the amount of PDL1 on cancer cells. PDL1 is a protein that helps keep immune cells from attacking nonharmful cells in the body. Normally, the immune system fights foreign substances like viruses and bacteria, and not your own healthy cells. Some cancer cells have high amounts of PDL1. This allows the cancer cells to "trick" the immune system, and avoid being attacked as foreign, harmful substances.
Current PD-L1 testing is based on immunohistochemistry (IHC) methods. Immunohistochemistry (IHC) is the process whereby antibodies are used to detect proteins (antigens) in cells within a tissue section (for instance liver, pancreas or the heart).
PD-L1 is a ligand that binds to PD-1 (programmed cell death-1), expressed on activated T cells, to evade anti-tumor responses. PD-L1 plays a role in inhibiting T cell activation and proliferation and has emerged as an important target in cancer treatment. PD-L1 protein detection by immunohistochemistry (IHC) testing is widely used as a predictive biomarker assay for anti–PD-1/PD-L1 therapies.
PIK3CA is a gene that encodes a lipid kinase involved in multiple signaling pathways. These pathways influence cellular functions such as growth, death, and proliferation. PIK3CA mutations activate the PI3K-PTEN-AKT pathway, which is downstream from both the EGFR and the RAS-RAF-MAPK pathways. PIK3CA mutations may cause oncogenic transformation independent of RAS or RAF mutations.
PIK3CA mutations occur in about 15% to 30% of breast, endometrial, and colon cancers. They occur less frequently in lung cancer and other types of cancer. Presence of PIK3CA mutations is associated with poor prognosis and lack of response to specific therapies in patients with breast, endometrial, or colon cancer.
The global PD-L1 and PIK3CA Testing market was valued at US$ 521.8 million in 2023 and is anticipated to reach US$ 1964.3 million by 2030, witnessing a CAGR of 20.6% during the forecast period 2024-2030.
The classification of PD-L1 and PIK3CA Testing Product includes PD-L1 Testing and PIK3CA Testing. PD-L1 accounted for a share of 80% in the global PD-L1 and PIK3CA Testing Product market.
PD-L1 and PIK3CA Testing Product is widely used in Hospital, Diagnostic Center and Other. In PD-L1 and PIK3CA Testing Product market, the Diagnostic Center holds an important share in terms of Application.
North America is the largest consumption place, with a market share nearly 57% . Following North America, Europe is the second largest consumption place with the market share of 28%.
Market competition is intense. Agilent Technologies, Roche, QIAGEN, Amoy Diagnostics, ACCB Biotech, etc. The top five vendors held 84% of the market share.
This report aims to provide a comprehensive presentation of the global market for PD-L1 and PIK3CA Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PD-L1 and PIK3CA Testing.
Report Scope
The PD-L1 and PIK3CA Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global PD-L1 and PIK3CA Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the PD-L1 and PIK3CA Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Roche
QIAGEN
EntroGen
Amoy Diagnostics
ACCB Biotech
Segment by Type
PD-L1 Testing
PIK3CA Testing
Segment by Application
Hospital
Diagnostic Center
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of PD-L1 and PIK3CA Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PD-L1 Testing
1.2.3 PIK3CA Testing
1.3 Market by Application
1.3.1 Global PD-L1 and PIK3CA Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 and PIK3CA Testing Market Perspective (2019-2030)
2.2 PD-L1 and PIK3CA Testing Growth Trends by Region
2.2.1 Global PD-L1 and PIK3CA Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 PD-L1 and PIK3CA Testing Historic Market Size by Region (2019-2024)
2.2.3 PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2025-2030)
2.3 PD-L1 and PIK3CA Testing Market Dynamics
2.3.1 PD-L1 and PIK3CA Testing Industry Trends
2.3.2 PD-L1 and PIK3CA Testing Market Drivers
2.3.3 PD-L1 and PIK3CA Testing Market Challenges
2.3.4 PD-L1 and PIK3CA Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue
3.1.1 Global Top PD-L1 and PIK3CA Testing Players by Revenue (2019-2024)
3.1.2 Global PD-L1 and PIK3CA Testing Revenue Market Share by Players (2019-2024)
3.2 Global PD-L1 and PIK3CA Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PD-L1 and PIK3CA Testing Revenue
3.4 Global PD-L1 and PIK3CA Testing Market Concentration Ratio
3.4.1 Global PD-L1 and PIK3CA Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PD-L1 and PIK3CA Testing Revenue in 2023
3.5 PD-L1 and PIK3CA Testing Key Players Head office and Area Served
3.6 Key Players PD-L1 and PIK3CA Testing Product Solution and Service
3.7 Date of Enter into PD-L1 and PIK3CA Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 and PIK3CA Testing Breakdown Data by Type
4.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Type (2019-2024)
4.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2025-2030)
5 PD-L1 and PIK3CA Testing Breakdown Data by Application
5.1 Global PD-L1 and PIK3CA Testing Historic Market Size by Application (2019-2024)
5.2 Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America PD-L1 and PIK3CA Testing Market Size (2019-2030)
6.2 North America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)
6.4 North America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PD-L1 and PIK3CA Testing Market Size (2019-2030)
7.2 Europe PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)
7.4 Europe PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PD-L1 and PIK3CA Testing Market Size (2019-2030)
8.2 Asia-Pacific PD-L1 and PIK3CA Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PD-L1 and PIK3CA Testing Market Size (2019-2030)
9.2 Latin America PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)
9.4 Latin America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PD-L1 and PIK3CA Testing Market Size (2019-2030)
10.2 Middle East & Africa PD-L1 and PIK3CA Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Detail
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies PD-L1 and PIK3CA Testing Introduction
11.1.4 Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.1.5 Agilent Technologies Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche PD-L1 and PIK3CA Testing Introduction
11.2.4 Roche Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.2.5 Roche Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN PD-L1 and PIK3CA Testing Introduction
11.3.4 QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.3.5 QIAGEN Recent Development
11.4 EntroGen
11.4.1 EntroGen Company Detail
11.4.2 EntroGen Business Overview
11.4.3 EntroGen PD-L1 and PIK3CA Testing Introduction
11.4.4 EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.4.5 EntroGen Recent Development
11.5 Amoy Diagnostics
11.5.1 Amoy Diagnostics Company Detail
11.5.2 Amoy Diagnostics Business Overview
11.5.3 Amoy Diagnostics PD-L1 and PIK3CA Testing Introduction
11.5.4 Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.5.5 Amoy Diagnostics Recent Development
11.6 ACCB Biotech
11.6.1 ACCB Biotech Company Detail
11.6.2 ACCB Biotech Business Overview
11.6.3 ACCB Biotech PD-L1 and PIK3CA Testing Introduction
11.6.4 ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2019-2024)
11.6.5 ACCB Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global PD-L1 and PIK3CA Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PD-L1 Testing
Table 3. Key Players of PIK3CA Testing
Table 4. Global PD-L1 and PIK3CA Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global PD-L1 and PIK3CA Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global PD-L1 and PIK3CA Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global PD-L1 and PIK3CA Testing Market Share by Region (2019-2024)
Table 8. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global PD-L1 and PIK3CA Testing Market Share by Region (2025-2030)
Table 10. PD-L1 and PIK3CA Testing Market Trends
Table 11. PD-L1 and PIK3CA Testing Market Drivers
Table 12. PD-L1 and PIK3CA Testing Market Challenges
Table 13. PD-L1 and PIK3CA Testing Market Restraints
Table 14. Global PD-L1 and PIK3CA Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global PD-L1 and PIK3CA Testing Market Share by Players (2019-2024)
Table 16. Global Top PD-L1 and PIK3CA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing as of 2023)
Table 17. Ranking of Global Top PD-L1 and PIK3CA Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by PD-L1 and PIK3CA Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players PD-L1 and PIK3CA Testing Product Solution and Service
Table 21. Date of Enter into PD-L1 and PIK3CA Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global PD-L1 and PIK3CA Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2019-2024)
Table 25. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global PD-L1 and PIK3CA Testing Revenue Market Share by Type (2025-2030)
Table 27. Global PD-L1 and PIK3CA Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2019-2024)
Table 29. Global PD-L1 and PIK3CA Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global PD-L1 and PIK3CA Testing Revenue Market Share by Application (2025-2030)
Table 31. North America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific PD-L1 and PIK3CA Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific PD-L1 and PIK3CA Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa PD-L1 and PIK3CA Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa PD-L1 and PIK3CA Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Agilent Technologies Company Detail
Table 47. Agilent Technologies Business Overview
Table 48. Agilent Technologies PD-L1 and PIK3CA Testing Product
Table 49. Agilent Technologies Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 50. Agilent Technologies Recent Development
Table 51. Roche Company Detail
Table 52. Roche Business Overview
Table 53. Roche PD-L1 and PIK3CA Testing Product
Table 54. Roche Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 55. Roche Recent Development
Table 56. QIAGEN Company Detail
Table 57. QIAGEN Business Overview
Table 58. QIAGEN PD-L1 and PIK3CA Testing Product
Table 59. QIAGEN Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 60. QIAGEN Recent Development
Table 61. EntroGen Company Detail
Table 62. EntroGen Business Overview
Table 63. EntroGen PD-L1 and PIK3CA Testing Product
Table 64. EntroGen Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 65. EntroGen Recent Development
Table 66. Amoy Diagnostics Company Detail
Table 67. Amoy Diagnostics Business Overview
Table 68. Amoy Diagnostics PD-L1 and PIK3CA Testing Product
Table 69. Amoy Diagnostics Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 70. Amoy Diagnostics Recent Development
Table 71. ACCB Biotech Company Detail
Table 72. ACCB Biotech Business Overview
Table 73. ACCB Biotech PD-L1 and PIK3CA Testing Product
Table 74. ACCB Biotech Revenue in PD-L1 and PIK3CA Testing Business (2019-2024) & (US$ Million)
Table 75. ACCB Biotech Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PD-L1 and PIK3CA Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global PD-L1 and PIK3CA Testing Market Share by Type: 2023 VS 2030
Figure 3. PD-L1 Testing Features
Figure 4. PIK3CA Testing Features
Figure 5. Global PD-L1 and PIK3CA Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global PD-L1 and PIK3CA Testing Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Diagnostic Center Case Studies
Figure 9. Others Case Studies
Figure 10. PD-L1 and PIK3CA Testing Report Years Considered
Figure 11. Global PD-L1 and PIK3CA Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global PD-L1 and PIK3CA Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global PD-L1 and PIK3CA Testing Market Share by Region: 2023 VS 2030
Figure 14. Global PD-L1 and PIK3CA Testing Market Share by Players in 2023
Figure 15. Global Top PD-L1 and PIK3CA Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 and PIK3CA Testing as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by PD-L1 and PIK3CA Testing Revenue in 2023
Figure 17. North America PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)
Figure 19. United States PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)
Figure 23. Germany PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific PD-L1 and PIK3CA Testing Market Share by Region (2019-2030)
Figure 31. China PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)
Figure 39. Mexico PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa PD-L1 and PIK3CA Testing Market Share by Country (2019-2030)
Figure 43. Turkey PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia PD-L1 and PIK3CA Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Agilent Technologies Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 47. QIAGEN Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 48. EntroGen Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 49. Amoy Diagnostics Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 50. ACCB Biotech Revenue Growth Rate in PD-L1 and PIK3CA Testing Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
